Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02952729
Title Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mersana Therapeutics
Indications

stomach cancer

lung non-small cell carcinoma

breast adenocarcinoma

Therapies

XMT-1522

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33607 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field